Pretreating DC vaccines with siIDO in vitro silenced expression of indoleamine 2,3-DiOxygenase (IDO, an immunosuppressive enzyme) and achieved better tumor-eliminating effects in the murine breast cancer models [272]. The gene discussed is IDO2; the disease is breast carcinoma.